| Discovery-based science education: functional genomic dissection in Drosophila by undergraduate researchers J Chen, GB Call, E Beyer, C Bui, A Cespedes, A Chan, J Chan, S Chan, ... PLoS biology 3 (2), e59, 2005 | 104 | 2005 |
| Transition to a virtual multidisciplinary tumor board during the COVID‐19 pandemic: University of Pittsburgh experience H Dharmarajan, JL Anderson, S Kim, S Sridharan, U Duvvuri, RL Ferris, ... Head & neck 42 (6), 1310-1316, 2020 | 89 | 2020 |
| Pediatric sarcomas: translating molecular pathogenesis of disease to novel therapeutic possibilities JL Anderson, CT Denny, WD Tap, N Federman Pediatric research 72 (2), 112-121, 2012 | 69 | 2012 |
| Dragon enhances BMP signaling and increases transepithelial resistance in kidney epithelial cells Y Xia, JL Babitt, R Bouley, Y Zhang, N Da Silva, S Chen, Z Zhuang, ... Journal of the American Society of Nephrology 21 (4), 666-677, 2010 | 45 | 2010 |
| Genomewide Clonal Analysis of Lethal Mutations in the Drosophila melanogaster Eye: Comparison of the X Chromosome and Autosomes GB Call, JM Olson, J Chen, N Villarasa, KT Ngo, AM Yabroff, S Cokus, ... Genetics 177 (2), 689-697, 2007 | 45 | 2007 |
| Evaluation of In Vitro Activity of the Class I PI3K Inhibitor Buparlisib (BKM120) in Pediatric Bone and Soft Tissue Sarcomas JL Anderson, A Park, R Akiyama, WD Tap, CT Denny, N Federman PloS one 10 (9), e0133610, 2015 | 43 | 2015 |
| Oncogenic fusion protein EWS/FLI1 down-regulates gene expression by both transcriptional and posttranscriptional mechanisms KA France, JL Anderson, A Park, CT Denny Journal of Biological Chemistry 286 (26), 22750-22757, 2011 | 36 | 2011 |
| Phosphoproteomic profiling reveals IL6-mediated paracrine signaling within the Ewing sarcoma family of tumors JL Anderson, B Titz, R Akiyama, E Komisopoulou, A Park, WD Tap, ... Molecular cancer research 12 (12), 1740-1754, 2014 | 26 | 2014 |
| Risks and complications of thyroglossal duct cyst removal JL Anderson, K Vu, YM Haidar, EC Kuan, T Tjoa The Laryngoscope 130 (2), 381-384, 2020 | 21 | 2020 |
| Effects of a provincial-wide implementation of screening for distress on healthcare professionals' confidence and understanding of person-centered care in oncology R Tamagawa, S Groff, J Anderson, S Champ, A Deiure, J Looyis, P Faris, ... Journal of the National Comprehensive Cancer Network 14 (10), 1259-1266, 2016 | 21 | 2016 |
| Prospective immunotherapies in childhood sarcomas: PD1/PDL1 blockade in combination with tumor vaccines TS Nowicki, JL Anderson, N Federman Pediatric Research 79 (3), 371-377, 2016 | 17 | 2016 |
| Analysis of clinical features of mammary analog secretory carcinoma using the surveillance, epidemiology, and end results database JL Anderson, YM Haidar, WB Armstrong, T Tjoa JAMA Otolaryngology–Head & Neck Surgery 145 (1), 91-93, 2019 | 14 | 2019 |
| Surgical factors associated with patient-reported quality of life outcomes after free flap reconstruction of the oral cavity JE Jimenez, ML Nilsen, WE Gooding, JL Anderson, NI Khan, LJ Mady, ... Oral oncology 123, 105574, 2021 | 9 | 2021 |
| Otolaryngology consult protocols in the setting of COVID-19: the University of Pittsburgh approach H Dharmarajan, MA Belsky, JL Anderson, S Sridharan Annals of Otology, Rhinology & Laryngology 131 (1), 12-26, 2022 | 8 | 2022 |
| The effect of opioids on the efficacy of immunotherapy in recurrent/metastatic squamous cell carcinoma of the head and neck NN Scheff, ML Nilsen, J Li, AL Harris, R Acharya, A Swartz, RW Hsieh, ... Oral oncology 140, 106363, 2023 | 4 | 2023 |
| Small extracellular vesicles as biomarkers of response in recurrent/metastatic HNSCC patients treated with immunotherapy DP Zandberg, CS Hong, A Swartz, R Hsieh, J Anderson, RL Ferris, ... BJC reports 2 (1), 70, 2024 | 3 | 2024 |
| Evaluation of radiomics as a predictor of efficacy and the tumor immune microenvironment in anti‐PD‐1 mAb treated recurrent/metastatic squamous cell carcinoma of the head and … DP Zandberg, S Zenkin, M Ak, P Mamindla, V Peddagangireddy, R Hsieh, ... Head & Neck 47 (1), 129-138, 2025 | 1 | 2025 |
| 1003 TIM-3+ natural killer cell dysfunction is driven by galectin-9 in head and neck squamous cell carcinoma J Wang, H Li, A Kulkarni, J Anderson, L Arantes, H Banerjee, LP Kane, ... Journal for ImmunoTherapy of Cancer 11 (Suppl 1), 2023 | | 2023 |
| Evaluation of small extracellular vesicles as biomarkers of efficacy with anti-PD-1 mAb therapy in patients with recurrent/metastatic HNSCC. DP Zandberg, CS Hong, A Swartz, RW Hsieh, JL Anderson, RL Ferris, ... Journal of Clinical Oncology 41 (16_suppl), 6042-6042, 2023 | | 2023 |
| 490 Galectin-9 drives TIM-3+ natural killer cell dysfunction in head and neck squamous cell carcinoma L Vujanovic, J Wang, H Li, A Kulkarni, J Anderson, L Arantes, H Banerjee, ... Journal for ImmunoTherapy of Cancer 10 (Suppl 2), 2022 | | 2022 |
